Skip to main content
SpringerLink
Log in

Reply to Periclou et al.: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

The Original Article was published on 11 July 2019

A Review Article was published on 19 June 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Periclou A, Riccobene T, Kapás M, et al. Comment on: “Clinical pharmacokinetics of atypical antipsychotics: an update”. Clin Pharmacokinet. 2019. https://doi.org/10.1007/s40262-019-00795-9

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mauri MC, Paletta S, Di Pace C, et al. Clinical pharmacokinetics of atypical antipsychotics: an update. Clin Pharmacokinet. 2018;57(12):1493–528. https://doi.org/10.1007/s40262-018-0664-3.

    Article  CAS  PubMed  Google Scholar 

  3. Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44:195–235.

    Article  Google Scholar 

  4. Nakamura T, Kubota T, Iwakaji A, et al. Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment). Drug Des Devel Ther. 2016;10:327–38.

    Article  CAS  Google Scholar 

  5. Carrothers T, Willavize S, Jaworowicz DJ, et al. Relationship of cariprazine plasma concentration to efficacy and safety in patients with schizophrenia or bipolar mania [poster]. American Psychiatric Association (APA) Annual Meeting; 14–18 May 2016; Atlanta. https://www.simulations-plus.com/resource/relationship-cariprazine-plasma-concentration-efficacy-safety-patients-schizophrenia-bipolar-mania/. Accessed 13 June 2019.

Download references

Author information

Authors and Affiliations

  1. Clinical Psychopharmacology Unit, Department of Neuroscience and Mental Health, Clinical Psychiatry, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Via F.Sforza 35, Milan, 20122, Italy

    Massimo Carlo Mauri

Authors
  1. Massimo Carlo Mauri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Carlo Mauri.

Ethics declarations

Funding

No external funding was used in the preparation of this reply.

Conflict of interest

Massimo Carlo Mauri has no conflicts of interest that are directly relevant to the contents of this reply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mauri, M.C. Reply to Periclou et al.: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”. Clin Pharmacokinet 58, 1217–1218 (2019). https://doi.org/10.1007/s40262-019-00796-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-019-00796-8

Search

Navigation